- Home
- ASML vs ABBV Comparison
ASML vs ABBV Comparison
Compare ASML & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASML
- ABBV
- Stock Information
- Founded
- ASML 1984
- ABBV 2012
- Country
- ASML Netherlands
- ABBV United States
- Employees
- ASML N/A
- ABBV N/A
- Industry
- ASML Industrial Machinery/Components
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- ASML Technology
- ABBV Health Care
- Exchange
- ASML Nasdaq
- ABBV Nasdaq
- Market Cap
- ASML 265.4B
- ABBV 312.8B
- IPO Year
- ASML 1995
- ABBV N/A
- Fundamental
- Price
- ASML $677.27
- ABBV $186.17
- Analyst Decision
- ASML Buy
- ABBV Buy
- Analyst Count
- ASML 6
- ABBV 22
- Target Price
- ASML $918.00
- ABBV $211.81
- AVG Volume (30 Days)
- ASML 2.3M
- ABBV 9.7M
- Earning Date
- ASML 04-16-2025
- ABBV 04-25-2025
- Dividend Yield
- ASML 0.93%
- ABBV 3.53%
- EPS Growth
- ASML 22.60
- ABBV N/A
- EPS
- ASML 23.97
- ABBV 2.34
- Revenue
- ASML $33,269,497,396.00
- ABBV $57,367,000,000.00
- Revenue This Year
- ASML $16.91
- ABBV $7.79
- Revenue Next Year
- ASML $12.66
- ABBV $7.92
- P/E Ratio
- ASML $28.25
- ABBV $79.52
- Revenue Growth
- ASML 17.67
- ABBV 5.45
- 52 Week Low
- ASML $578.51
- ABBV $153.58
- 52 Week High
- ASML $1,110.09
- ABBV $218.66
- Technical
- Relative Strength Index (RSI)
- ASML 51.95
- ABBV 49.41
- Support Level
- ASML $614.06
- ABBV $168.54
- Resistance Level
- ASML $687.53
- ABBV $180.50
- Average True Range (ATR)
- ASML 29.72
- ABBV 7.87
- MACD
- ASML 5.25
- ABBV 0.79
- Stochastic Oscillator
- ASML 86.80
- ABBV 90.75
About ASML ASML Holding N.V. New York Registry Shares
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).